docetaxel anhydrous has been researched along with bryostatin 1 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (bryostatin 1) | Trials (bryostatin 1) | Recent Studies (post-2010) (bryostatin 1) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 727 | 46 | 174 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaye, SB; Schwartsmann, G; Workman, P | 1 |
1 review(s) available for docetaxel anhydrous and bryostatin 1
| Article | Year |
|---|---|
Laboratory and phase I studies of new cancer drugs.
Topics: Antineoplastic Agents; Bryostatins; Camptothecin; Docetaxel; Humans; Lactones; Macrolides; Neoplasms; Paclitaxel; Taxoids | 1992 |
1 trial(s) available for docetaxel anhydrous and bryostatin 1
| Article | Year |
|---|---|
Laboratory and phase I studies of new cancer drugs.
Topics: Antineoplastic Agents; Bryostatins; Camptothecin; Docetaxel; Humans; Lactones; Macrolides; Neoplasms; Paclitaxel; Taxoids | 1992 |